Live tape
Top 8, mentions 7d11,559SPCX2,367 mentions▲ +0.08TSLA1,886 mentions▲ +0.05META1,804 mentions▲ +0.05GOOGL1,731 mentions▲ +0.02NFLX1,030 mentions▲ +0.03QQQ970 mentions▲ +0.05NVDA914 mentions▲ +0.07AMZN857 mentions▲ +0.07

Equity · Healthcare

PHAT

NASDAQ

Phathom Pharmaceuticals (PHAT)

$7.02 −0.07% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 22, 2026

Reddit mentioned PHAT 25 times in the 30 days to 23 October 2026, across 2 of the communities we track. All of them were scored for sentiment: 28% read bullish, 12% bearish and 60% neither. Reddit data updated 23 October 2026.

Price · Chart
63 sessions
$12 $6 27 Jul 22 Oct

The line runs $11.94 on 27 July through $7.02 on 22 October, on a scale from $6 to $12. Days the market did not trade hold the previous close, flat.

Market cap $567.9M
52-week range $6.72 – $18
Avg volume 82.4K
Mentions · 30d 25
Net sentiment +0.03

as of Oct 21, 2026

Phathom Pharmaceuticals (PHAT) · crowd attention × price

Share ↗
25 mentions

Day22 Oct 2026

MENTIONS20–4 / day
PRICE$7.02$6.5–$8.0
MOOD100%EXTREMELY BULLISH
PHAT over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for; the crowd's sentiment as a scattered ribbon against a dashed neutral rule — each point is the mix over the 7 days ending that day, above the rule more mentions bullish than bearish and below it the reverse — denser on days with more mentions.per day01234% bull10%30%50%70%90%usd$6.5$7.0$7.5$8.024 Sep1 Oct9 Oct16 Oct23 Oct
PHAT over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for; the crowd's sentiment as a scattered ribbon against a dashed neutral rule — each point is the mix over the 7 days ending that day, above the rule more mentions bullish than bearish and below it the reverse — denser on days with more mentions.50% BULL24 Sep9 Oct23 Oct
The Distributed Sentinel 23 Oct 2026

PHAT's busiest day for Reddit mentions came at the bearish end of this window's sentiment — 33% bullish on 2 October, against 100% bullish at the other end

This chart in words

The chart plots daily Reddit mentions of PHAT over the 30 days to 23 October 2026: 25 in total, busiest on 2 October with 3, and 2 on the last day counted. The line is the daily close over the same window: $7 on 24 September, $7.02 on 22 October. Of those days, 21 were trading sessions and the other 9 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove. Sentiment — the bullish share of the mentions that took a side, where the chart's dashed rule marks the 50% at which bullish and bearish are even — ran from 33% bullish to 100% bullish over the 8 days that carried enough mentions to measure. 20 days either fell under the 5-mention floor or carried no bullish or bearish mention at all, and so carry no sentiment point.

Phathom Pharmaceuticals (PHAT) on Reddit · 30d

n = 25 scored · Method

In the 30 days to 23 Oct 2026, Phathom Pharmaceuticals drew 25 Reddit mentions in the finance subreddits we track, 25 of them scored for sentiment.

PHAT

28% bullish

Overall market sentiment

54% bullish

PHAT reads 26 points less bullish than overall market sentiment. Same measure; same 30-day window.

Where PHAT is discussed

(30d)
r/wallstreetbets 96% 24 +0.03
r/ausfinance 4% 1 +0.10

Moves with PHAT

co-mention r · 31 obs

Tickers whose daily Reddit volume rose and fell with PHAT's. Co-discussion, not price.

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations) · Method

Phathom Pharmaceuticals (PHAT) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 6 Oct 2026

In the 90 days to 23 Oct 2026, no Phathom Pharmaceuticals insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 2

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
06 Oct 2026 Narula Sanjeev Chief Financial & Bus. Officer Tax withheld 13,485 $91K
03 Sep 2026 Breedlove Robert Charles Principal Accounting Officer Tax withheld 460 $4K

Phathom Pharmaceuticals (PHAT) reported financials

SEC EDGAR XBRL SEC EDGAR

Phathom Pharmaceuticals reported revenue of $175.1M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$221.2M.

Figure Reported Period
Revenue $175.1M 31 Dec 2025 fiscal year
Net income −$221.2M 31 Dec 2025 fiscal year
Diluted EPS −$3.03 31 Dec 2025 fiscal year
Total assets $327.1M 30 Jun 2026 at period end
Total equity −$344.3M 30 Jun 2026 at period end

Phathom Pharmaceuticals (PHAT) earnings

SEC EDGAR

Phathom Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.21; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.21 $74M
31 Mar 2026 Q1 2026 −$0.37 $58M
31 Dec 2025 FY 2025 −$3.03 $175M
30 Sep 2025 Q3 2025 −$0.41 $50M
30 Jun 2025 Q2 2025 −$1.05 $40M
31 Mar 2025 Q1 2025 −$1.31 $29M
31 Dec 2024 FY 2024 −$5.29 $55M
30 Sep 2024 Q3 2024 −$1.32 $16M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Phathom Pharmaceuticals (PHAT) institutional holders (13F)

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a Phathom Pharmaceuticals position for the quarter ended 30 Jun 2026 — a combined $68.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Held (±25%) −16.1% shares 3,375,834 $36.6M
Point72 Asset Management New position 1,022,193 $11.1M
Marshall Wace Held (±25%) −22.6% shares 666,090 $7.2M
Two Sigma Investments Held (±25%) +7.7% shares 519,076 $5.6M
Renaissance Technologies Trimmed −26.0% shares 226,400 $2.5M
Citadel Advisors Trimmed −51.7% shares 184,901 $2.0M
AQR Capital Management Added +143.2% shares 134,901 $1.5M
D. E. Shaw & Co. Trimmed −27.8% shares 95,660 $1.0M
Man Group Added +60.4% shares 48,679 $528K

Phathom Pharmaceuticals (PHAT) fails-to-deliver

SEC CNS data SEC

On 22 Sep 2026, 1,968 shares of Phathom Pharmaceuticals failed to deliver (about $15K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
22 Sep 2026 1,968 $15K 0.002%
21 Sep 2026 5,115 $38K 0.006%
17 Sep 2026 37 $285 <0.001%
08 Sep 2026 336 $3K <0.001%

Phathom Pharmaceuticals (PHAT): frequently asked questions

From live data

Have Phathom Pharmaceuticals insiders bought or sold shares recently?

In the 90 days to 23 Oct 2026, no Phathom Pharmaceuticals insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

How many institutions hold Phathom Pharmaceuticals?

9 of the 45 institutional funds we track reported a Phathom Pharmaceuticals position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Phathom Pharmaceuticals had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Phathom Pharmaceuticals is dated 22 Sep 2026, when 1,968 shares failed to deliver.

When did Phathom Pharmaceuticals last report earnings?

Phathom Pharmaceuticals last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.21; no next date is announced in SEC filings yet.

What exchange is Phathom Pharmaceuticals listed on?

Phathom Pharmaceuticals trades on NASDAQ under the ticker PHAT.

What is Reddit saying about Phathom Pharmaceuticals?

Phathom Pharmaceuticals was mentioned 7 times in the last 7 days across the finance subreddits we track, and 25 times over the trailing 30 days. Of 25 classified mentions, 28% read bullish, 12% bearish and 60% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARValuation computed from SEC EDGAR filings